Urology • Andrology • ReSurgeClinic

Prostate Diseases Assessment in Kyrenia / Northern Cyprus

Prostate diseases include benign prostate enlargement, urinary complaints, PSA elevation, prostatitis-like symptoms and prostate cancer suspicion. At ReSurgeClinic, the patient’s age, complaint, PSA history, examination, ultrasound, MRI and biopsy requirement are evaluated together; the aim is to avoid both unnecessary fear and delayed diagnosis.

PSA assessmentBPH / HoLEPMRI and biopsy decisionPersonalized follow-up

During the first consultation

The main complaint, duration of symptoms, previous treatments, accompanying diseases, medications, expectations and relevant examination findings are evaluated together.

Clinical focus

The aim is not to apply the same treatment to every patient, but to understand the underlying mechanism and choose the safest suitable step.

Treatment logic

Follow-up, medical treatment, minimally invasive procedures or surgery are discussed step by step according to the patient’s condition.

Which problems are included under prostate diseases?

Frequent urination, weak stream, nocturia, incomplete emptying, PSA elevation, prostatitis-like symptoms and prostate cancer suspicion may all be part of prostate evaluation.

The important point is to interpret these findings together rather than looking at a single value or symptom.

Benign prostate enlargement and urinary complaints

BPH can affect urinary flow and bladder emptying. The degree of obstruction, residual urine and quality of life determine whether follow-up, medication or surgery is more appropriate.

HoLEP is considered in suitable patients when endoscopic laser treatment is clinically appropriate.

PSA elevation and prostate cancer suspicion

PSA elevation does not automatically mean cancer; prostate enlargement, infection, recent procedures and individual factors can affect PSA. However, it must be taken seriously and compared with previous values.

When necessary, prostate MRI, risk classification and MRI fusion biopsy may be considered to avoid unnecessary biopsy while not missing clinically important cancer.

Individualized follow-up in Kyrenia / Northern Cyprus

Decisions in prostate diseases are rarely memorized decisions made in a single visit. PSA follow-up, uroflowmetry, ultrasound, MRI, biopsy results or postoperative follow-up are planned according to risk.

The aim is to reduce symptoms, relieve unnecessary fear and move to the right treatment at the right time when needed.

BPH

Urinary flow, nocturia, bladder impact and need for medication or surgery are evaluated together.

HoLEP suitability

Endoscopic laser prostate surgery is planned according to prostate size, obstruction and general condition.

PSA and MRI assessment

PSA is interpreted with examination, previous PSA trend, family history and MRI findings.

MRI fusion biopsy

Targeted biopsy is decided according to clinical risk and imaging findings.

Frequently asked questions

Does high PSA always mean prostate cancer?

No. PSA may rise for several reasons, but it should be assessed by a urologist.

Is HoLEP suitable for every BPH patient?

No. Suitability depends on urinary flow, residual urine, symptoms, prostate size and general health.

How can I book an appointment?

You can request an appointment through the online form or WhatsApp line. Existing PSA, MRI, ultrasound or pathology reports are helpful.